Framework for high-tech homecare medicines services, North East and Yorkshire NHS
Closed United Kingdom · Medicines
| Buyer | Leeds Teaching Hospitals NHS Trust, for the North East and Yorkshire NHS Pharmaceutical Purchasing Consortium |
|---|---|
| Reference | C425492 (2026/S 000-096590) |
| Closing date | 16 November 2026, 12:00 UK time (the notice gives no time zone) |
| Products | 6 lots: compounded desferrioxamine, compounded antimicrobials, compounded chemotherapy and monoclonal antibodies, other compounded products, metabolic disorders, other non-compounded high-tech homecare. Estimated GBP 200m excl. VAT. |
| Notes | The deadline was extended from 4 Nov 2026. This is a framework for homecare medicines services (supply plus delivery to patients). Register and bid on the Atamis e-sourcing portal (health-family.force.com). Runs Apr 2027 to Mar 2029, extendable to Mar 2031. |
PharmaTradz is not the buyer. Read the full tender documents and any addenda on the buyer's site before bidding; they always prevail over this summary.
Typical documents for a medicines tender
- Registration in the buyer's country, or the alternative the tender accepts (for example WHO prequalification)
- GMP certificate for the manufacturing site and a certificate of pharmaceutical product (CoPP)
- Certificates of analysis, samples, stability data and labelling in the required language
- Bid security, authorisation letters and price schedules in the buyer's format
Need a supplier for this tender?
Tell us the lots, strengths and quantities. We match registered, GMP-certified manufacturers and can help with tender documents.
Request supplier quotesNew tenders in United Kingdom
We email you when new tenders for this country are listed. Confirm first; unsubscribe any time.
Other open tenders
- Framework for unlicensed imported medicines (wave 2), North East and Yorkshire NHS (United Kingdom, 30 Nov)
- All-Wales supply of generic oral liquid medicines (United Kingdom, 14 Dec)
- Backup supply of injectable medicines if CENABAST cannot deliver, Hospital del Salvador (Chile, 23 Nov)
- Carfilzomib 60 mg for the SUS oncology programme, Ministry of Health (Brazil, 26 Nov)
- Framework agreement for oral anticancer medicines for Hospital Clinico San Carlos, Madrid (Spain, 27 Nov)
- Medicines in 5 ATC packages, Boleslawiec regional psychiatric hospital (Poland, 27 Nov)